According to the study, a gene found in some bats can cut the SARS-CoV-2 virus’s production by up to 90%, which may pave the way for novel therapeutic strategies to treat viral illnesses.
Research
Using a novel animal model of Alzheimer’s disease, the study raises the possibility of a breakthrough in therapeutic approaches.
Surgery to remove the tumor is the standard of care for individuals with stage III or IV clear cell renal cell carcinoma.
The study discovered that the body may produce more ID3+ T cells in response to certain signals, opening the door for better therapies like CAR T cell therapy.
A novel method predicts how a certain DNA sequence will organize itself in the cell nucleus in a matter of minutes as opposed to days.
Physicians were required to decide on cancer patients’ treatments, initially without the aid of technology and later with AI’s support.
The interdisciplinary research team headed by Professors Seyun Kim, Gwangrog Lee, and Won-Ki Cho from the Department of Biological Sciences revealed crucial mechanisms regulating gene expression in animal cells on January 22, according to KAIST.
Data from this 28-country multi-institutional effort helped the Food and Drug Administration (FDA) approve this combination more quickly in December 2024, giving patients with BRAF V600E-mutant mCRC a new and effective first-line treatment choice.
The group tested over 20 million individual cells using both self-supervised learning techniques, then contrasted the outcomes with those of traditional learning techniques.
The combination immunotherapy affected distant metastases in addition to the treated tumors. It increased the sensitivity of melanomas to checkpoint inhibitors and decreased the creation of new metastases, hence reducing malignant relapses.
